Search results for

Nick Harkaway grew up hearing his dad read drafts of his George Smiley novels. He picked up le Carré's beloved spymaster character in the novel Karla's Choice. Originally broadcast Oct. 23, 2024.

GIVĒON treats performance as therapy, pouring out his heart like a bottle of wine. The R&B singer treats us to ballads and anthems of heartache, backed by strings and horns.

If you're tempted to bail on potentially fun events becuase you feel awkward, read this. Level up your small talk game and practice social courage with six tips from psychologists.

Friday is the deadline for the government to release files related to the life and death of convicted sex offender Jeffrey Epstein. There are still questions about what will be published and when.

An unpredictable and exciting college football season is coming to a close. This weekend's first-round slate is set up for two tight games and two blowouts — but in the playoffs, anything goes.

NPR's Leila Fadel tags along for lunch with Elazar Sontag, the Washington Post's new food critic.

The chip industry in China is hustling to overcome a Western tech choke hold, even as President Trump appears poised to loosen U.S. chip restrictions.

The suspect in the Brown University shooting was found dead, police say, Friday is the deadline for the DOJ to release the Epstein files, Trump to add his own name to the Kennedy Center.

Cuba is watching nervously as the U.S. ramps up pressure on Venezuela, threatening a lifeline and deepening the island's isolation.

Palestinians in Gaza are slowly bringing back Christmas celebrations after more than two years of war. The Holy Family Church in Gaza City gathered this week to decorate the church.

NPR's Steve Inskeep looks back at President Trump's behavior over the past week with Jonathan Karl of ABC News. He's the author of "Retribution: Donald Trump and the Campaign That Changed America."

Flu cases are soaring in New York and picking up in other parts of the country. Experts worry it will be another bad season. COVID and RSV have been less of a problem, but they're also on the rise.